| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fc3e5cb7a2da33ea01dae32f31bef542 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-52 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-19 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-81
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-99
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-22 |
| filingDate |
1996-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4baad30de684812759d8a4de0de7af42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f7e9e7a816c249a223ca0d4f382f331
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e1a55f78bcdf0c2f78ccb4b71a44e352
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1857f8513cc98e5799a266a980183beb |
| publicationDate |
1998-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-H1080281-A |
| titleOfInvention |
Novel protein and method for producing the same |
| abstract |
PROBLEM TO BE SOLVED: To provide a novel protein having a cysteine protease inhibitory activity and a method for producing the same. A novel protein having a cysteine protease inhibitory activity of 13 ± 2 kDa or 16 ± 2 kDa as measured by SDS-PAGE under reducing and non-reducing conditions. A method for producing the protein, wherein human milk is subjected to affinity chromatography using a carboxymethylated papain-immobilized carrier, the adsorbed fraction is eluted under alkaline conditions, and purified by gel filtration and reverse phase chromatography. The protein of the present invention exhibits an antibody production promoting effect and an inhibitory effect on bone resorption of osteoclasts, and is useful as an antiviral agent, a therapeutic agent for osteoporosis and the like. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6607743-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004050116-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1602284-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1040833-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1161881-A3 |
| priorityDate |
1996-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |